Neural tube defect rates before and after food fortification with folic acid

被引:93
作者
Mills, JL [1 ]
Signore, C [1 ]
机构
[1] NICHD, Pediat Epidemiol Sect, DESPR, HHS,NIH, Bethesda, MD 20892 USA
关键词
neural tube defects; folic acid; fortified food; folate; birth defects; enriched food;
D O I
10.1002/bdra.20075
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
BACKGROUND: Since 1998, enriched cereal grains sold in the United States have been fortified with folic acid, to reduce the incidence of neural tube defects (NTDs). The Centers for Disease Control and Prevention (CDC) recently reported that NTD rates have decreased 26% since fortification, but that additional effort is needed to achieve the national goal of a 50% reduction. However, accurate determination of NTD rates requires counting antenatally detected cases; the CDC study noted that the number of prenatally diagnosed cases was likely underestimated. METHODS AND RESULTS: We examined studies from the United States and Canada that compared rates of NTDs before and after very similar fortification programs were instituted in each country. U.S. studies had incomplete ascertainment of prenatally diagnosed NTD cases, and as a result, underreported the number of NTDs prevented. Canadian studies, in which ascertainment was more complete, showed decreases in NTD rates up to 54%. CONCLUSIONS: There is a strong correlation between the completeness of ascertainment and the percentage decrease in NTD rates. Studies that identify cases best show that folic acid fortification is preventing around 50% of NTDs. The percentage of NTDs that are folate-preventable in the United States is uncertain, but is probably 50-60%. Thus, we may be quite close to achieving the optimum level of protection at current fortification levels. Published 2004 Wiley-Liss, Inc.
引用
收藏
页码:844 / 845
页数:2
相关论文
共 15 条
[1]  
[Anonymous], 1996, Federal Register, V61, P8781
[2]  
Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P362
[3]   Trend in prevalence of neural tube defects in Quebec [J].
De Wals, P ;
Rusen, ID ;
Lee, NS ;
Morin, P ;
Niyonsenga, T .
BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY, 2003, 67 (11) :919-923
[4]  
Gucciardi E, 2002, CAN MED ASSOC J, V167, P237
[5]  
HONEIN MA, 2001, JAMA-J AM MED ASSOC, V286, P2236
[6]   Impact of the MHFR C677T polymorphism on risk of neural tube defects: case-control study [J].
Kirke, PN ;
Mills, JI ;
Molloy, AM ;
Brody, LC ;
O'Leary, VB ;
Daly, L ;
Murray, S ;
Conley, M ;
Mayne, PD ;
Smith, O ;
Scott, JM .
BRITISH MEDICAL JOURNAL, 2004, 328 (7455) :1535-1536
[7]   PERICONCEPTIONAL USE OF MULTIVITAMINS AND THE OCCURRENCE OF NEURAL-TUBE DEFECTS [J].
MULINARE, J ;
CORDERO, JF ;
ERICKSON, JD ;
BERRY, RJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1988, 260 (21) :3141-3145
[8]  
*ONT MIN FIN, 2001, CENS 2001 HIGHL VIS
[9]  
Persad VL, 2002, CAN MED ASSOC J, V167, P241
[10]   Association of neural tube defects and folic acid food fortification in Canada [J].
Ray, JG ;
Meier, C ;
Vermeulen, MJ ;
Boss, S ;
Wyatt, PR ;
Cole, DEC .
LANCET, 2002, 360 (9350) :2047-2048